A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies - ScienceDirect
Prostate Cancer Calculators
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involv
Developing a national, Web-based, patient-focused, prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK
Predicting clinical end points: treatment nomograms in prostate cancer - ScienceDirect
The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink
Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and
Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy - ScienceDirect
Critical review of prostate cancer predictive tools | Future Oncology
Active Surveillance of Prostate Cancer: Advances for More-Accurate Risk Assessment | Memorial Sloan Kettering Cancer Center
Prostate Cancer Prediction Tools — Metrovan Urology
Validation of metastatic assay in the Memorial Sloan Kettering Cancer... | Download Table
PDF) External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer
Month 134 – PSA Results | Dan's Journey through Prostate Cancer
Memorial Sloan-Kettering Cancer Center criteria. | Download Table
Cancers | Free Full-Text | Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for
Prostate Cancer (Part 1.2)- Management Of Unfavorable Intermediate Risk Prostate Cancer - YouTube
Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations
Prostate Cancer Cure Rates
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -
Developing a national, Web-based, patient-focused prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK
